Delivery Order SPE2DR25D7909-SPE2DR26FX7FQ
Award Date 1/29/26
Potential Completion Date 1/30/26
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,566.00 firm fixed-price delivery order for Procainamide 1 gram/10 mL vials on November 24, 2025, with completion targeted for November 25, 2025. The award, which carries no set-aside designation, represents a competitively awarded delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on January 5, 2026, with a ceiling value of $1,577.22. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by January 6, 2026. The award will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,187.81 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This is a firm fixed-price contract with an ultimate completion date of January 12, 2026, and represents a competitively awarded, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. AmerisourceBergen Drug Corp is a subsidiary of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 20, 2025, with completion scheduled for November 21, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,426.53 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on January 24, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price, non-set-aside delivery order represents a critical pharmaceutical supply requirement for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a delivery order valued at $2,512.96 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on a firm fixed-price basis. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-competitive delivery order under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $3,164.53. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $7,465.68. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,791.77 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials. This is a firm fixed price delivery order with an ultimate completion date of December 18, 2025, and represents a non-competitive set-aside procurement. The award is performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains operations as a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,505.03. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...